Blood viscosity changes in experimentally Trypanosoma cruzi-infected rats

被引:0
作者
Berra, HH
Piaggio, E
Revelli, SS
Luquita, A
机构
[1] Univ Nacl Rosario, Fac Ciencias Med, Catedra Fis Biol, Dept Ciencias Fisiol, RA-2000 Rosario, Santa Fe, Argentina
[2] Univ Nacl Rosario, Fac Ciencias Med, Catedra Fisiol Humana, Dept Ciencias Fisiol, RA-2000 Rosario, Santa Fe, Argentina
[3] Univ Nacl Rosario, Fac Ciencias Med, Inst Inmunol, Dept Ciencias Fisiol, RA-2000 Rosario, Santa Fe, Argentina
关键词
blood viscosity; erythrocyte shape; hemorheological variables; Trypanosoma cruzi;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microcirculatory alterations would explain focal lesions found in Chagas' cardiomyopathy. Trypanosoma cruzi (T. cruzi) infection induces host blood properties modifications and defensive responses capable of producing blood hyperviscosity, an ischemic risk factor able to affect microvascular blood flow. We studied whole blood viscosity (eta(b)) and plasmatic and cellular factors influencing it in rats, 7 and 14 days after experimental infection with T. cruzi. Increased plasma viscosity (eta(p)) was found in infected versus control rats and it was correlated with high blood parasite levels at 7 days and enhanced gamma-globulin fraction concentration at 14 days. The hematocrit, mean corpuscular volume (MCV) and eta(b) were higher in 14 days infected rats vs. 7 days and control animals. Also, electron microscopy observation showed morphological changes in red blood cells (RBC) at 7 and 14 days post-infection, with increased proportion of echinocyte and stomatocyte shapes transformation. In our rat model of Chagas' disease, BPL, increased plasmatic protein concentration, enhanced MCV and RBC shapes transformation would determine blood hyperviscosity, cause of microvascular blood flow abnormalities.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 40 条
[1]   Structure of the glycosylphosphatidylinositol-anchor of the trans-sialidase from Trypanosoma cruzi metacyclic trypomastigote forms [J].
Agusti, R ;
Couto, AS ;
Campetella, O ;
Frasch, ACC ;
de Lederkremer, RM .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1998, 97 (1-2) :123-131
[2]  
Amara F, 2003, CLIN HEMORHEOL MICRO, V28, P21
[3]  
BESSIS M, 1973, PHYSL PATHOLOGY ULTR, P1
[4]   A SUPERFAMILY OF TRYPANOSOMA-CRUZI SURFACE-ANTIGENS [J].
CAMPETELLA, O ;
SANCHEZ, D ;
CAZZULO, JJ ;
FRASCH, ACC .
PARASITOLOGY TODAY, 1992, 8 (11) :378-381
[5]   TRANS-SIALIDASE FROM TRYPANOSOMA-CRUZI EPIMASTIGOTES IS EXPRESSED AT THE STATIONARY-PHASE AND IS DIFFERENT FROM THE ENZYME EXPRESSED IN TRYPOMASTIGOTES [J].
CHAVES, LB ;
BRIONES, MRS ;
SCHENKMAN, S .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1993, 61 (01) :97-106
[6]   Pathogenesis of chronic chagas heart disease:: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation [J].
Dávila, DF ;
Rossell, O ;
de Bellabarba, GA .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (01) :107-109
[7]   Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection [J].
De Souza, AP ;
Tanowitz, HB ;
Chandra, M ;
Shtutin, V ;
Weiss, LM ;
Morris, SA ;
Factor, SM ;
Huang, H ;
Wittner, M ;
Shirani, J ;
Jelicks, LA .
PARASITOLOGY RESEARCH, 2004, 92 (06) :496-501
[8]  
DINTENFASS L, 1985, CLIN HEMORHEOL, V5, P191
[9]  
Eterovic D, 1995, CLIN HEMORHEOL, V15, P841
[10]  
FUJII T, 1979, BIOCHEM PHARMACOL, V28, P613